Marshall Wace North America’s LivaNova LIVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$43.3M Buy
546,980
+272,919
+100% +$22.4M 0.18% 120
2021
Q2
$23.1M Buy
274,061
+39,253
+17% +$3.23M 0.1% 226
2021
Q1
$17.3M Buy
234,808
+225,261
+2,359% +$16.1M 0.07% 278
2020
Q4
$632K Sell
9,547
-11,910
-56% -$662K ﹤0.01% 1037
2020
Q3
$970K Buy
+21,457
New +$1.04M 0.01% 813
2020
Q2
Sell
-35,491
Closed -$1.61M 1329
2020
Q1
$1.61M Buy
35,491
+16,010
+82% +$1.04M 0.01% 527
2019
Q4
$1.47M Sell
19,481
-15,277
-44% -$1.16M 0.01% 639
2019
Q3
$2.56M Buy
+34,758
New +$2.68M 0.01% 494
2019
Q1
Sell
-181,979
Closed -$16.6M 1749
2018
Q4
$16.6M Buy
181,979
+101,598
+126% +$10.9M 0.16% 118
2018
Q3
$9.96M Buy
+80,381
New +$9.48M 0.07% 217
2017
Q3
Sell
-41,269
Closed -$2.52M 1399
2017
Q2
$2.52M Buy
+41,269
New +$2.33M 0.02% 689

Other funds holding LIVN

Marshall Wace North America's LIVN Position: Q3 2021 in Review

Marshall Wace North America increased its LivaNova (LIVN) stake by 100% in Q3 2021, buying an estimated $22.4M and bringing the position to 546,980 shares worth $43.3M. The position accounts for 0.18% of the portfolio, ranked #120.

Marshall Wace North America first reported a position in LIVN in Q2 2017 and has held it in 11 quarters since. 214 funds tracked by Wall St. Rank hold LIVN as of Q3 2021.

  • Marshall Wace North America held 546,980 shares of LivaNova worth $43.3M as of Q3 2021.
  • Marshall Wace North America bought 272,919 LivaNova shares in Q3 2021, an estimated $22.4M.
  • LivaNova made up 0.18% of Marshall Wace North America's portfolio in Q3 2021, its #120 holding.
  • Marshall Wace North America first reported a position in LivaNova in Q2 2017 and has held it in 11 quarters since.
  • 214 funds tracked by Wall St. Rank held LivaNova as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.